In response to your letter of April 26 concerning the nomenclature of the retrovirus group, I have the following thoughts.
I agree it should not be called AIDS virus. I also think it should be called HTLV because that designation is historical
and does not distinguish between the tumor inciting activity of HTLV 1 and 2 and the depressant activity of the AIDS virus.
I would think that the designation should have the human and the T-cell specific concepts and somehow should convey the immunodepressant
or cytocidal effect. I would propose something like HTIV or HTCV.